Stock market news
Headlines from permitted publisher feeds and official institutions. Similar reports are grouped into one story with a source count; every item links to the original.
- Dave & Buster’s interim CFO Cory Hatton buys $25,999 in stock
- Barclays reiterates Robinhood stock rating on strong Q3 volumes
- Genfit shares jump 4% on tripled Iqirvo royalties, cash runway beyond 2028
- Waldron long seen as next Goldman CEO. The question is when
- Why is Genfit stock gaining today?
- Tata leadership transition, IPO unlikely to impact ratings, S&P Global says
- Pharming shares fall after CEO steps down over strategy dispute
- CNBC Daily Open: AI’s creators sound the alarm — while others keep building the infrastructure
When the AI boom first took off, companies were competing to see what their AI models can do. Now, they reassure investors of what their models CAN'T do.
- UBS cuts PagSeguro stock price target on TPV growth concerns
- Earnings call transcript: HORNBACH Group posts solid Q2 2026 sales growth
- Earnings call transcript: HORNBACH posts solid H1 2026 results, keeps guidance cautious
- Exclusive-Anthropic leaders to control AI lab via ’Founder LLC’ to promote public good over market forces
- FTSE 100 today: Stocks edge up as UK shop price inflation slows
- Bernstein downgrades Pan Pacific International stock rating on margin pressure
- The stock market usually booms in the November-to-April stretch. This indicator suggests otherwise.
Jim Paulsen thinks lagged indicators suggest the usual ‘best buying season’ for stocks may not be applicable this time and backtesting his model to 1970 shows meagre returns.
- Cytokinetics CEO Robert Blum sells $490,949 in stock
- Roth/MKM initiates Nautilus Biotechnology stock with buy rating
- Roth/MKM initiates Rapid Micro Biosystems stock with buy rating
- Japan stocks lower at close of trade; Nikkei 225 down 0.47%
- Stadler Rail names Philipp Brunner CEO from 2027, targets profit growth